Resolvins are lipids that 'resolve' the inflammation that normally follows injury or disease, returning the body back to normal. Therapeutic administration of one such resolvin can halt memory loss in a common preclinical model of Down syndrome, a finding that could also be relevant to memory loss in Alzheimer's disease, report researchers. This resolvin could enhance the body's ability to heal and resolve inflammation.